Joseph Levy, PhD, is a health economist who works on methods and policy to improve value-based decision making in healthcare.
Research Interests
Health Economics; Cost-effectiveness Analysis; Drug Pricing; Orthopedic Trauma;
Additional Links
Experiences & Accomplishments
Select Publications
Levy JF, Rosenberg MA, Vanness DJ. “A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analysis”. Value in Health. 2018; 6:677-683.
Levy JF, Khairnar R, Louie AV, Showalter TN, Mullins CD, Mishra MV. Evaluating the cost-effectiveness of hydrogel rectal spacer in prostate cancer radiation therapy. Practical radiation oncology. 2019 Mar 1;9(2):e172-9.
Levy JF, Ippolito BN, Jain A. Hospital Revenue Under Maryland’s Total Cost of Care Model During the COVID-19 Pandemic, March-July 2020. JAMA. 2021 Jan 26;325(4):398-400.
Levy J, Chowdhury ZM, Socal MP, Trujillo AJ. Changes associated with the entry of a biosimilar in the insulin glargine market. JAMA internal medicine. 2021 Oct 1;181(10):1405-7.
Levy JF, Reider L, Scharfstein DO, Pollak AN, Morshed S, Firoozabadi R, Archer KR, Gary JL, O'Toole RV, Castillo RC, Quinnan SM, Kempton LB, Jones CB, Bosse MJ, MacKenzie EJ; METRC. The 1-Year Economic Impact of Work Productivity Loss Following Severe Lower Extremity Trauma. J Bone Joint Surg Am. 2022 Apr 6;104(7):586-593.
Ippolito B, Levy JF. Expanding Medicare Coverage Of Anti-Obesity Medicines Could Increase Annual Spending By 3.1BillionTo 6.1 Billion. Health Affairs. 2024 Sep 1:10-377.